Misoprostol: all 309 studies that test it

Page 3 of 4. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory DrugsCompletedNCT02202967Phase 3
• Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical TrialStatus unknownNCT02168881Not applicable
• Treatment of Postpartum Hemorrhage With Misoprostol: Fever StudyCompletedNCT02163616Phase 3
• Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean SectionCompletedNCT02141321Phase 2/3
• Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus MisoprostolCompletedNCT02086994Phase 3
• Impact of Misoprostol on Blood Loss In Myomectomy OperationsCompletedNCT02061657Phase 3
• The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)CompletedNCT02053922Phase 3
• Misoprostol for Second Trimester Termination of PregnancyCompletedNCT02048098Phase 3
• Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of PregnancyStatus unknownNCT02013960Not applicable
• Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel BleedingCompletedNCT01998776Phase 2/3
• 400mcg Sublingual Misoprostol as First Line TreatmentCompletedNCT01939457Not applicable
• Misoprostol for Cervical Priming Prior to Vacuum AspirationCompletedNCT01933360Phase 2
• The Obstetric Cook Double Balloon Catheter in Combination With Oral Misoprostol for Induction of LaborStatus unknownNCT01866488Phase 2
• Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum HemorrhageCompletedNCT01866241Phase 3
• Misoprostol Versus Oxytocin for Prevention of Post Partum HemorrhageCompletedNCT01863706Phase 1
• Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days GestationCompletedNCT01856985Phase 4
• Intraumbilical Misoprostol in Retained PlacentaCompletedNCT01840813Phase 1
• Misoprostol Administration Before Operative HysteroscopyCompletedNCT01805115Phase 3
• Induction With Foley OR Misoprostol (INFORM) StudyCompletedNCT01801410Phase 3
• Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in BangladeshCompletedNCT01798017Phase 4
• Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)CompletedNCT01768299Phase 4
• Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2CompletedNCT01765881Phase 2
• Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual MisoprostolStatus unknownNCT01762319Not applicable
• Use of Misoprostol in Case of Insertion Failure of Intrauterine ContraceptivesCompletedNCT01754649Phase 4
• Comparison of Sublingual Misoprostol Versus Lidocaine Spray for HysteroscopyCompletedNCT01718314Not applicable
• Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in SenegalCompletedNCT01713153Not applicable
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in CommunitiesWithdrawnNCT01710566Phase 3
• Study of the Use of Misoprostol to Decrease Bleeding During a MyomectomyCompletedNCT01700478Phase 4
• Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical AbortionCompletedNCT01678703Not applicable
• Intravaginal Misoprostol Versus Dinoprostone Before Diagnostik HysteroscopyStatus unknownNCT01620814Phase 4
• Repeated Doses of Misoprostol for Medical Treatment of Missed MiscarriageTerminatedNCT01615224Phase 2/3
• Optimum Misoprostol Dose Prior to Office HysteroscopyCompletedNCT01612065Phase 3
• Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized TrialStatus unknownNCT01600612Not applicable
• Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean SectionCompletedNCT01571323Phase 1/2
• Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in NigeriaCompletedNCT01539408Phase 1
• A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)CompletedNCT01510574Not applicable
• Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
• Comparitive Study of Two Misoprostol Regimen in Early Pregnancy TerminationCompletedNCT01508143Not applicable
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in MaliWithdrawnNCT01487278Not applicable
• Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home BirthsCompletedNCT01485562Not applicable
• Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at CesareanStatus unknownNCT01477840Phase 2/3
• Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of PregnancyStatus unknownNCT01475318Not applicable
• Sublingual Misoprostol & Isoflurane During Caesarean SectionCompletedNCT01466530Phase 2
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaCompletedNCT01462422Not applicable
• Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of LaborCompletedNCT01428037Phase 3
• Control of Blood Loss During Caesarean SectionCompletedNCT01412073Phase 3
• Sublingual Misoprostol for Induction of LaborCompletedNCT01406392Phase 4
• Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or OxytocinCompletedNCT01373359Phase 3
• Pharmacokinetics of Misoprostol With Titrated Oral AdministrationCompletedNCT01271257Phase 1
• Evaluation the Blood Loss in Pregnancies With Misoprostol-induced LabourCompletedNCT01231126Phase 4
• Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH)CompletedNCT01199159Not applicable
• Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in TunisiaCompletedNCT01173003Not applicable
• Misoprostol For Nulliparous Women Before HysteroscopyStatus unknownNCT01156948Phase 3
• A Prospective Randomized Comparison Trial on the Use of Mifepristone With Sublingual or Buccal Misoprostol for Medical Abortions of Less Than 9 Weeks GestationCompletedNCT01156688Phase 4
• Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of LaborCompletedNCT01140971Not applicable
• Non Surgical Management for Uterine Residua After Pregnancy Termination, Abortion or DeliveryTerminatedNCT01134926Phase 2
• Intrarectal Misoprostol in Postpartum HaemorrhageCompletedNCT01116050Phase 3
• Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum HaemorrhageTerminatedNCT01113229Phase 4
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum HemorrhageCompletedNCT01080846Not applicable
• Efficacy and Safety of Titrated Oral Misoprostol Solution for Labor Induction at TermCompletedNCT01070472Not applicable
• Optimal Treatment of MiscarriageCompletedNCT01033903Not applicable
• Cervical Priming With Misoprostol Prior to Operative HysteroscopyCompletedNCT01024270Phase 3
• Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous WomenCompletedNCT01001897Not applicable
• The Extended Gestational Age Medical Abortion StudyCompletedNCT00997347Phase 4
• Oral Titrated Misoprostol for Induction of LabourCompletedNCT00992524Not applicable
• Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))CompletedNCT00969982Not applicable
• Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)TerminatedNCT00957346Phase 3
• Vaginal Misoprostol for Cervical Ripening Prior to Endometrial BiopsyWithdrawnNCT00953641Phase 3
• Misoprostol for Second Trimester Termination of PregnancyCompletedNCT00945997Not applicable
• Treatment Regimens for Mifegyne and CytotecStatus unknownNCT00920465Phase 3
• Oral Misoprostol for Labor Augmentation: A Pilot StudyCompletedNCT00906126Phase 1
• Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in ErbilCompletedNCT00892229Phase 2
• The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral MisoprostolCompletedNCT00886860Phase 4
• Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)CompletedNCT00870272Not applicable
• Techniques to Improve Efficacy of Second Trimester Medical TerminationCompletedNCT00864799Not applicable
• Misoprostol in Termination of First Trimester Missed AbortionCompletedNCT00797693Not applicable
• Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded TrialCompletedNCT00784186Not applicable
• Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor AugmentationStatus unknownNCT00695331Phase 4
• Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical TreatmentCompletedNCT00674232Not applicable
• Misoprostol for the Treatment of Incomplete AbortionCompletedNCT00670761Not applicable
• Labour Induction With Misoprostol, Dinoprostone and Bard CatheterCompletedNCT00602095Phase 3
• Hysteroscopy After Pretreatment With Misoprostol and Estradiol TrialCompletedNCT00572819Phase 3
• Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at TermCompletedNCT00529295Phase 3
• Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days GestationCompletedNCT00482209Not applicable
• Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete AbortionCompletedNCT00466999Not applicable
• Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term PregnanciesStatus unknownNCT00432588Phase 1/2
• Misoprostol for Non-Viable PregnanciesCompletedNCT00426491Phase 3
• Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of PregnancyCompletedNCT00401440Phase 4
• Comparison of Misoprostol and PGE2 Gel for Induction of Labour in Women With Premature Rupture of Membranes at TermCompletedNCT00355966Phase 4
• Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at TermCompletedNCT00355303Phase 4
• Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days GestationCompletedNCT00330993Phase 2
• Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm GestationCompletedNCT00325026Phase 2
• A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy TerminationCompletedNCT00310921Phase 2
• Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study)CompletedNCT00299754Phase 3
• Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days GestationCompletedNCT00286208Not applicable
• Mifepristone at Same Time Multicenter StudyCompletedNCT00269568Phase 4
• Treatment of Late Abortion: Evacuatio Uteri or Conservative TreatmentStatus unknownNCT00256009Phase 4
• Oral Misoprostol Before Endometrial BiopsyCompletedNCT00200226Phase 3
• Mifepristone and Misoprostol for Fetal DemiseCompletedNCT00177372Phase 4
• Oral Versus Vaginal Misoprostol for Induction of LaborCompletedNCT00148473Phase 2/3

← Misoprostol overview